Evidence-based medicine - engineering the Learning Healthcare System.

Institute of Medicine, USA.
Studies in health technology and informatics 01/2010; 153:145-57.
Source: PubMed

ABSTRACT Whether for the generation or application of evidence to guide healthcare decisions, the success of evidence-based medicine is grounded in principles common to engineering. In the Learning Healthcare System envisioned by the Institute of Medicine's (IOM) Roundtable on Evidence-Based Medicine, evidence emerges as a natural by-product of care delivery, which is thoroughly documented, pooled for continuous monitoring and analysis, integrated with insights from related studies, and fed back seamlessly to improve the consistency and appropriateness of care decisions by clinicians and their patients. Drawing from lessons shared at the IOM/NAE symposium, Engineering a Learning Healthcare System, this paper provides an overview of the state-of-play in health care today, some of its key challenges, the vision and features of a learning healthcare system, applicable commonalties and principles from engineering, and potential collaborative opportunities moving forward to the benefit of both fields.

  • [Show abstract] [Hide abstract]
    ABSTRACT: This article describes the development of a modeling hierarchy for complex enterprise networks. Drawing on the extant modeling literature, these network models are elaborated in terms of 4 salient problem characteristics: conversions, flows, controls, and social/organizational relationships. The authors relate these 4 characteristics to phenomena, representations, micromodels, macromodels, and modeling tools. The roles of information and incentives in complex enterprises networks are considered. Examples of 2 domains, global manufacturing and healthcare delivery, are woven through these discussions of alternative representations and models. The authors conclude by providing a structured comparison of these 2 domains, discussing theoretical and practical implications, and presenting opportunities for future enterprise transformation research.
    07/2011; 1(3):208-230. DOI:10.1080/19488289.2011.601397
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The learning health care system refers to the cycle of turning health care data into knowledge, translating that knowledge into practice, and creating new data by means of advanced information technology. The electronic Primary Care Research Network (ePCRN) was a project, funded by the U.S. National Institutes of Health, with the aim to facilitate clinical research using primary care electronic health records (EHRs). We identified the requirements necessary to deliver clinical studies via a distributed electronic network linked to EHRs. After we explored a variety of informatics solutions, we constructed a functional prototype of the software. We then explored the barriers to adoption of the prototype software within U.S. practice-based research networks. We developed a system to assist in the identification of eligible cohorts from EHR data. To preserve privacy, counts and flagging were performed remotely, and no data were transferred out of the EHR. A lack of batch export facilities from EHR systems and ambiguities in the coding of clinical data, such as blood pressure, have so far prevented a full-scale deployment. We created an international consortium and a model for sharing further ePCRN development across a variety of ongoing projects in the United States and Europe. A means of accessing health care data for research is not sufficient in itself to deliver a learning health care system. EHR systems need to use sophisticated tools to capture and preserve rich clinical context in coded data, and business models need to be developed that incentivize all stakeholders from clinicians to vendors to participate in the system.
    The Annals of Family Medicine 05/2012; 10(1):54-9. DOI:10.1370/afm.1313 · 4.57 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The first 100 years of drug regulation by the US Food and Drug Administration (FDA) have been sculpted by a series of tragedies and the consequent broadening of the FDA's authority by Congress. The distinguishing feature of the FDA's execution of its mission is that it has routinely turned to science as the primary basis for decision making, and for this reason, it is one of the world's most respected regulatory agencies. Regulatory science, currently defined by the FDA as the science that underpins its decisions, has been the foundation for the FDA's success since its inception. This review focuses on the role of science as the basis for FDA decision making. It examines how regulatory science has made the FDA's past successes possible and concludes with an overview of how the FDA might augment its science-based regulation in the future and what new policy alternatives might be necessary. Expected final online publication date for the Annual Review of Pharmacology and Toxicology Volume 53 is January 06, 2013. Please see for revised estimates.
    Annual Review of Pharmacology 10/2012; DOI:10.1146/annurev-pharmtox-011112-140159 · 18.52 Impact Factor